Updated
Updated · Scientific American · Oct 16
US Flu Positivity Hits 3.6% as Drifting H1N1 Drives Early Fall Surge
Updated
Updated · Scientific American · Oct 16

US Flu Positivity Hits 3.6% as Drifting H1N1 Drives Early Fall Surge

3 articles · Updated · Scientific American · Oct 16

Summary

  • CDC data show U.S. flu positivity reached 3.6% by Oct. 9, up sixfold from 0.6% a year earlier after activity began climbing in early September.
  • Region 9—Arizona, California, Hawaii and Nevada—hit 9.5% positivity, and 98.4% of recent positive tests were H1N1, suggesting the early rise is concentrated and strain-specific.
  • Experts say the circulating H1N1 has undergone antigenic drift, making it different from prior strains and the vaccine strain and potentially better able to evade existing immunity.
  • Researchers still say it is too early to judge how severe the winter season will be or how well current shots will perform, but they recommend vaccination now, before Thanksgiving at the latest.
  • Moderna's mFLUSIVA—the first mRNA seasonal flu vaccine, approved Aug. 5 for adults 50 and older—was 26.6% more effective than a standard shot in Phase 3, though access remains limited.

Insights

With the flu surging early in October 2026, could the mutating H1N1 strain outpace our current vaccines despite a reported match?
Will Moderna’s newly approved mRNA flu vaccine revolutionize our fight against sudden viral shifts before the winter peak hits?
Can AI-driven predictions of viral mutations eventually replace our reactive seasonal vaccine updates as early flu surges become the norm?